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In August 1996, the International Health
Law Committee, International Law and
Practice Section, American Bar Association,
sponsored a program entitled “Law and
Emerging and Re-Emerging Infectious Dis-
eases” to examine how the emergence and
reemergence of infectious diseases affects
international and U.S. federal, state, and
local law. The issues addressed included
international legal rules on infectious
disease control and the need for their
revision in light of emerging and reemerging
infectious diseases; emerging infectious
diseases and U.S. federal law, especially as it
affects the mission of public health agencies;
and the importance of state and local law in
dealing with emerging infectious diseases.
Common themes included the challenge
posed by emerging infectious diseases as law
at every level (international, national, and
local) is involved and law in various forms
(treaties, constitutions, statutes, and regu-
lations) is affected; the need for legal reform
at the international and U.S. federal, state,
and local levels; the challenges posed by a
complex jurisdictional environment (e.g.,
World Health Organization’s relationship to
independent states and U.S. public health
agencies’ relationships to state govern-
ments); in considering legal reform, the need
to balance competing policy objectives, such
as the control of infectious diseases versus
the freedom of global trade and travel or
protecting the community versus privacy
rights; the interdependence of legal reform
efforts in that local and national implemen-
tation of revised international rules will be
critical to any global strategy; the need to
integrate the efforts of lawyers and public
health officials to effectively promote epide-
miologic principles and objectives; and the
massive scope of the emerging diseases
threat stemming from not only its global
reach but also the long list of causes behind
the emergence and reemergence of infectious
diseases (e.g., political and medical compla-
cency, international trade, global travel,
war, human behavior, environmental degra-
dation, urbanization, poverty, and inad-
equate public health infrastructures).
The International Health Law Commit-
tee program marks a first step in raising
awareness in the legal and public health
communities of the many and complex legal
issues involved in addressing emerging
infectious diseases.
For copies of program presentations and
other information, contact David P. Fidler by
e-mail at davidfidler@law.indiana.edu.
David P. Fidler
Indiana University School of Law
Bloomington, Indiana, USA
ABA Sponsors Program on Law and
Emerging Infectious Diseases
Emerging and reemerging infections
respect no national boundaries; therefore,
they were an appropriate topic for the first
“global medical theme issue,” introduced in
January 1996. This global theme issue was
conceived by three editors, Linda Hawes
Clever, The Western Journal of Medicine,
Magne Nylenna, Journal of the Norwegian
Medical Association, and George D. Lundberg,
Journal of the American Medical Associa-
tion, who in 1995 invited the editors of 78
journals worldwide to participate. A year
later, 36 journals in 21 countries on six
continents published more than 200 articles
pertaining to emerging and reemerging
global microbial threats (1). The articles
addressed topics ranging from factors
contributing to increasing antimicrobial
resistance to the impact of global warming on
infectious disease. While some solutions
were suggested, the global issue primarily
served as a call to medical communities and
people worldwide to identify contributing
factors and begin to develop strategies to
control emergent infections.
Following this note is a bibliography of
articles published by the 36 journals
participating in the global theme issue.
Margaret A. Winker
Journal of the American Medical Association
Chicago, Illinois, USA
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The conference on “Emerging Foodborne
Pathogens: Implications and Control,” March
24-26, 1997, Radisson Plaza Hotel at Mark
Center, Alexandria, Virginia, USA, is orga-
nized by the International Life Sciences
Institute (ILSI), ILSI North America Techni-
cal Committee on Food Microbiology, the
U.S. Centers for Disease Control and Pre-
vention, Department of Agriculture, and
Food and Drug Administration, in coopera-
tion with the Food and Agriculture Organi-
zation of the United Nations, and the Pan
American Health Organization/World Health
Organization.  The conference will review
the lessons learned and knowledge gained
concerning the emergence/reemergence and
dissemination of food-related microbial
threats to health; identify factors that foster
emergence/reemergence and dissemination
of these hazards; identify scientific and food
safety strategies to address emerging
foodborne microbial hazards; and identify
future research needs.  The conference will
be of special interest to food protection and
public health professionals, including micro-
biologists, epidemiologists, physicians, and
health policy makers; industry, academic,
and government researchers; and others
interested in microbial food safety hazards.
For program and registration informa-
tion, contact
Ms. Diane Dalisera
Emerging Foodborne Pathogens Conference
International Life Sciences Institute (ILSI)
1126 Sixteenth Street, NW
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